Pancreatic Stone Protein Testing Market Size

  • Report ID: 4566
  • Published Date: Nov 24, 2025
  • Report Format: PDF, PPT

Pancreatic Stone Protein Testing Market Outlook:

Pancreatic Stone Protein Testing Market size was over USD 4.43 billion in 2025 and is poised to exceed USD 5.9 billion by 2035, witnessing over 2.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of pancreatic stone protein testing is estimated at USD 4.55 billion.

The growth of the market can be attributed to the globally rising prevalence of chronic diseases, caused by pancreatic stone formation. Some of these diseases include acute appendicitis, diabetes, gallstones, and optic atrophy, which is expected to drive the demand for global pancreatic stone protein testing market during the forecast period. It was observed that, in American Indians, gallstones are prevalent at a rate of about 55% to 65%, while the rate in white adults in developed countries is approximately 8% to 15%. Likewise, the rate of acute pancreatitis symptoms is higher in developing countries as well as in developed countries. For instance, the annual incidence of acute pancreatic in the U.S. ranges from 20 to 50 per 100,000 population.

The global pancreatic stone protein testing market size is expected to expand during the forecast period owing to its potential for detecting life-threatening diseases and monitoring the response to treatment. Additionally, the increasing cases of chronic & hereditary pancreatitis and pancreatic cancer worldwide are estimated to propel the growth of the global pancreatic stone protein testing market over the forecast period. According to the National Center for Biotechnology Information, a pancreatic cancer diagnosis is the seventh leading cause of cancer-related death in the world. There have been 458,918 new cases of pancreatic cancer recorded globally in 2018, and there are estimated to be 355,317 new cases occurring until the year 2040. Furthermore, assay techniques such as ELISA and immunoassay devices are some of the global pancreatic stone protein testing market trends expected to fuel the market growth during the forecast period.


Pancreatic-Stone-Protein-Testing-overview

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of pancreatic stone protein testing is estimated at USD 4.55 billion.

The global pancreatic stone protein testing market size was over USD 4.43 billion in 2025 and is anticipated to witness a CAGR of around 2.9%, crossing USD 5.9 billion revenue by 2035.

By 2035, North America is projected to secure the majority revenue share in the Pancreatic Stone Protein Testing Market, supported by extensive technological adoption, a large patient pool, and robust healthcare infrastructure, attributed to rising awareness and strong regional healthcare spending.

Key players in the market include CUSABIO TECHNOLOGY LLC, LifeSpan BioSciences, Inc, Abbexa Limited, Boster Biological Technology CO LTD, Aviva Systems Biology Corporation, Glenmed Professional Healthcare Solutions., CREATIVE DIAGNOSTICS, Inc, Biomol GmbH, AMS Biotechnology (Europe) Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos